EUVIMEDEUVIMED entdecken
Crossref

Systemic Ivermectin Administration Reduces Aqueous Tear Production and Affects Ocular Surface Health in Clinically Healthy Dogs

Yakup Kocaman iD, Latif Emrah Yanmaz

Veterinary Ophthalmology · 2026-05 · 29 (3)

DOI: 10.1111/vop.70180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Ophthalmology, online erschienen am 10.04.2026. Verfasst von Yakup Kocaman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Veterinary Medicine, Yozgat Bozok University, Yozgat, Turkiye. Hauptthemen laut MEDLINE: Ivermectin, Tears, Antiparasitic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to evaluate the effects of ivermectin administration on aqueous tear production and ocular surface health in dogs and to investigate its potential association with quantitative keratoconjunctivitis sicca (KCS).

Methods

A total of 128 mixed‐breed dogs were included: 64 ivermectin‐treated and 64 untreated controls. Lacrimal secretion and ocular surface status were assessed using Schirmer tear test I (STT‐I), fluorescein staining, and corneal opacity scoring. Data were analyzed with nonparametric tests, with p < 0.05 considered significant.

Results

At 36 h after treatment, STT‐I values were significantly reduced from baseline in the ivermectin group ( p < 0.001), whereas no significant change was observed in controls ( p > 0.05). Reduction in aqueous tear production (ΔSTT‐I) was greater in ivermectin‐treated dogs (−4.38 ± 2.7 mm/min, p < 0.001) than in controls (−0.14 ± 0.9 mm/min; p < 0.001). Mean STT‐I at 36 h was lower in the treated group (6.05 ± 3.5 mm/min) compared with controls (10.08 ± 3.2 mm/min; p < 0.001). Fluorescein uptake was observed more frequently in ivermectin‐treated dogs (32.8%, p = 0.001) than in controls (7.8%, p = 0.001). KCS severity scores were significantly higher in the ivermectin group ( p < 0.05), while the control median score was 1.

Conclusions

Routine systemic ivermectin treatment was associated with reduced aqueous tear production. The mechanism was not evaluated but may involve altered neural control of lacrimal secretion. Even at recommended doses, ivermectin may predispose susceptible dogs to subclinical dry eye; therefore, quantitative tear testing is advisable in dogs receiving ivermectin prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IvermectinTearsAntiparasitic AgentsAnimalsDogsFemaleMaleKeratoconjunctivitis SiccaDog Diseases

Stichwörter der Autor:innen

Schirmer tear testdogfluorescein stainingivermectinkeratoconjunctivitis siccaocular surface

Substanzen

IvermectinAntiparasitic Agents

Autor:innen und Institutionen

  • Department of Surgery, Faculty of Veterinary Medicine, Yozgat Bozok University, Yozgat, Turkiye.
  • Department of Surgery, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkiye.

ORCID-Profile: Yakup Kocaman

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Kocaman, Y., & Yanmaz, L. E. (2026). Systemic Ivermectin Administration Reduces Aqueous Tear Production and Affects Ocular Surface Health in Clinically Healthy Dogs. Veterinary Ophthalmology, 29(3). https://doi.org/10.1111/vop.70180

Vancouver

Kocaman Y, Yanmaz LE. Systemic Ivermectin Administration Reduces Aqueous Tear Production and Affects Ocular Surface Health in Clinically Healthy Dogs. Veterinary Ophthalmology. 2026;29(3). doi:10.1111/vop.70180

BibTeX
@article{Kocaman2026,
  author = {Kocaman, Yakup and Yanmaz, Latif Emrah},
  title = {Systemic Ivermectin Administration Reduces Aqueous Tear Production and Affects Ocular Surface Health in Clinically Healthy Dogs},
  journal = {Veterinary Ophthalmology},
  year = {2026},
  volume = {29},
  number = {3},
  doi = {10.1111/vop.70180}
}
Kostenlos starten →